The failure of an Alzheimer's disease drug made by Eli Lilly (
A late-stage study to assess Lilly's drug candidate, solanezumab, in people with mild dementia due to Alzheimer's
Like a contagion, the Lilly-stoked selling has spread to AC Immune, Axovant, Biogen, Merck and Roche. But there could be
Alzheimer's, characterized by the loss of brain cells...